Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Drug Discovery Today
|
September 8, 2001
Effective decision-making: progressing compounds through clinical development
C A. Shillingford, C W. Vose
British Journal of Cancer
|
July 1, 1973
Inhibition of metabolism and tumorigenesis of 15,16-dihydro-11-methyl-cyclopenta(A)phenanthren-17-one by 7,8-Benzflavone
M M Coombs, C W Vose
Biomedical Mass Spectrometry
|
January 1, 1978
Electron impact mass spectra of 1-methyl-oestra-1,3,5(10)-trienes having intact and 13,17-seco-D-ring structures
C W Vose, M M Coombs
Journal of Chromatography
|
February 27, 1985
Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma
Y Robinson, N Gerry, C W Vose
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 1, 1992
The Drug Metabolism Discussion Group 1991
R A Franklin, C W Vose, H Wiltshire
Journal of Chromatography
|
October 9, 1981
Liquid chromatographic analysis of an antimicrobial 5-nitroimidazolyl-2-sulphide derivative in biological fluids
C W Vose, P M Stevens, J P Dickens
British Journal of Clinical Pharmacology
|
June 1, 1978
Urinary D-glucaric acid and oral contraceptives
P M Stevens, C W Vose, R F Palmer
Carcinogenesis
|
January 1, 1981
Microsomal metabolites of the aryl hydrocarbon hydroxylase and tumour inhibitor 7,8-benzoflavone
M M Coombs, T S Bhatt, C W Vose
Carcinogenesis
|
January 1, 1981
Co-carcinogenicity of promoting agents
C W Vose, M M Coombs, T S Bhatt
Cancer Research
|
February 1, 1975
The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor
M M Coombs, T S Bhatt, C W Vose
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Drug Discovery Today
|
September 8, 2001
Effective decision-making: progressing compounds through clinical development
C A. Shillingford, C W. Vose
British Journal of Cancer
|
July 1, 1973
Inhibition of metabolism and tumorigenesis of 15,16-dihydro-11-methyl-cyclopenta(A)phenanthren-17-one by 7,8-Benzflavone
M M Coombs, C W Vose
Biomedical Mass Spectrometry
|
January 1, 1978
Electron impact mass spectra of 1-methyl-oestra-1,3,5(10)-trienes having intact and 13,17-seco-D-ring structures
C W Vose, M M Coombs
Journal of Chromatography
|
February 27, 1985
Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma
Y Robinson, N Gerry, C W Vose
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 1, 1992
The Drug Metabolism Discussion Group 1991
R A Franklin, C W Vose, H Wiltshire
Journal of Chromatography
|
October 9, 1981
Liquid chromatographic analysis of an antimicrobial 5-nitroimidazolyl-2-sulphide derivative in biological fluids
C W Vose, P M Stevens, J P Dickens
British Journal of Clinical Pharmacology
|
June 1, 1978
Urinary D-glucaric acid and oral contraceptives
P M Stevens, C W Vose, R F Palmer
Carcinogenesis
|
January 1, 1981
Microsomal metabolites of the aryl hydrocarbon hydroxylase and tumour inhibitor 7,8-benzoflavone
M M Coombs, T S Bhatt, C W Vose
Carcinogenesis
|
January 1, 1981
Co-carcinogenicity of promoting agents
C W Vose, M M Coombs, T S Bhatt
Cancer Research
|
February 1, 1975
The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor
M M Coombs, T S Bhatt, C W Vose
Page
of 4